SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-20-000973
Filing Date
2020-07-07
Accepted
2020-07-07 17:41:14
Documents
1
Period of Report
2020-07-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6658
  Complete submission text file 0001123292-20-000973.txt   9193
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TOMTEBODAVAGEN 23A SOLNA V7 SE 171 65
Business Address TOMTEBODAVAGEN 23A SOLNA V7 SE 171 65 08-524 860 70
KDev Investments AB (Reporting) CIK: 0001789888 (see all company filings)

State of Incorp.: V7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 201016780

Mailing Address TOMTEBODAVAGEN 23A SOLNA V7 SE 171 65
Business Address TOMTEBODAVAGEN 23A SOLNA V7 SE 171 65 08-524 860 70
Karolinska Development AB (Reporting) CIK: 0001789932 (see all company filings)

State of Incorp.: V7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 201016781

Mailing Address TOMTEBODAVAGEN 23A SOLNA V7 SE 171 65
Business Address TOMTEBODAVAGEN 23A SOLNA V7 SE 171 65 08-524 860 70
KCIF Co-Investment Fund KB (Reporting) CIK: 0001789966 (see all company filings)

State of Incorp.: V7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 201016782